Unveiling the Genetic Defense Against Alzheimer's and Parkinson's
Researchers have identified a gene allele, known as DR4, that offers more than a 10% average reduction in the risk of Alzheimer’s and Parkinson’s diseases. The study suggests a potential role of the tau protein in both conditions. The DR4 allele prompts the immune system to target a specific segment of tau, potentially disrupting the formation of harmful brain aggregates. This discovery opens doors for targeted vaccines that could slow or even halt the progression of these neurodegenerative diseases.